Sign in
4

Changes in Ownership

Fulcrum Therapeutics, Inc. Filed Acc 0000899243-22-002878

Options or other derivatives

  • Chief Medical Officer acquired 59,744 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Morabito Christopher Chief Medical Officer 2022-01-19 Grant or award · Stock Option (right to buy) +59,744 59,744 D
Loading xslF345X03/doc4.xml…